BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dunet V, Halkic N, Prior JO, Anaye A, Meuli RA, Sempoux C, Denys A, Schmidt S. Detection and Viability of Colorectal Liver Metastases After Neoadjuvant Chemotherapy: A Multiparametric PET/CT-MRI Study. Clin Nucl Med. 2017;42:258-263. [PMID: 28166142 DOI: 10.1097/rlu.0000000000001538] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhu H, Xu D, Zhang X, Li X, Xing B, Sun Y. Prediction of Therapeutic Effect to Treatment in Patients with Colorectal Liver Metastases Using Functional Magnetic Resonance Imaging and RECIST Criteria: A Pilot Study in Comparison between Bevacizumab-Containing Chemotherapy and Standard Chemotherapy. Ann Surg Oncol. [DOI: 10.1245/s10434-021-11101-y] [Reference Citation Analysis]
2 Drewes R, Pech M, Powerski M, Omari J, Heinze C, Damm R, Wienke A, Surov A. Apparent Diffusion Coefficient Can Predict Response to Chemotherapy of Liver Metastases in Colorectal Cancer. Acad Radiol 2021;28 Suppl 1:S73-80. [PMID: 33008734 DOI: 10.1016/j.acra.2020.09.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Tlostanova MS, Dolbov AL, Stanzhevskii AA. Capabilities of <sup>18</sup>F-FDG PET/CT in the differential diagnosis of colorectal liver metastases. Ann hir gepatol 2019;24:18-29. [DOI: 10.16931/1995-5464.2019418-29] [Reference Citation Analysis]
4 Fouladi DF, Zarghampour M, Pandey P, Pandey A, Varzaneh FN, Ghasabeh MA, Khoshpouri P, Kamel IR. Baseline 3D-ADC outperforms 2D-ADC in predicting response to treatment in patients with colorectal liver metastases. Eur Radiol 2020;30:291-300. [PMID: 31209620 DOI: 10.1007/s00330-019-06289-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
5 Xu F, Tang B, Jin TQ, Dai CL. Current status of surgical treatment of colorectal liver metastases. World J Clin Cases 2018; 6(14): 716-734 [PMID: 30510936 DOI: 10.12998/wjcc.v6.i14.716] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
6 Hou G, Song R, Yang J, Zhang Y, Xiao C, Wang C, Yuan J, Chai T, Liu Z. Treatment effect of conversion therapy and its correlation with VEGF expression in unresectable rectal cancer with liver metastasis. Oncol Lett 2018;16:749-54. [PMID: 29963141 DOI: 10.3892/ol.2018.8758] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]